摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-5,6,7,8-四氢-1-萘酚 | 861339-92-6

中文名称
2-氨基-5,6,7,8-四氢-1-萘酚
中文别名
——
英文名称
2-amino-5,6,7,8-tetrahydronaphthalen-1-ol
英文别名
6-Amino-5-oxy-1.2.3.4-tetrahydro-naphthalin;2-Amino-5,6,7,8-tetrahydro-[1]naphthol;6-Amino-5-oxy-tetralin;6-Amino-tetralol-(5)
2-氨基-5,6,7,8-四氢-1-萘酚化学式
CAS
861339-92-6
化学式
C10H13NO
mdl
——
分子量
163.219
InChiKey
GQHYWPQAHVAGBI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:82a65c55a61732e07e4a1e14696a84bf
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,8-喹啉二酮2-氨基-5,6,7,8-四氢-1-萘酚 在 cobalt(II) acetate 、 溶剂黄146 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以33%的产率得到13-Oxa-2,8-diazapentacyclo[12.8.0.03,12.04,9.015,20]docosa-1(14),2,4(9),5,7,11,15(20),21-octaen-10-one
    参考文献:
    名称:
    Antitumor Agents. 5. Synthesis, Structure−Activity Relationships, and Biological Evaluation of Dimethyl-5H-pyridophenoxazin-5-ones, Tetrahydro-5H-benzopyridophenoxazin-5-ones, and 5H-Benzopyridophenoxazin-5-ones with Potent Antiproliferative Activity
    摘要:
    New antiproliferative compounds, dimethyl-5H-pyrido[3,2-a] phenoxazin-5-ones (1-6), tetrahydro-5-Hbenzopyrido[2,3-j]phenoxazin-5-ones (7-9), and 5H-benzopyrido[3,2-a] phenoxazin-5-ones (10-12) were synthesized and evaluated against representative human neoplastic cell lines. Dimethyl derivatives 1-6 were more active against carcinoma than leukemia cell lines. The tetrahydrobenzo derivatives 7-9 were scarcely active, whereas the corresponding benzo derivatives 10-12 showed notable cytotoxicity against a majority of the tested cell lines. Molecular modeling studies indicated that the high potency of 10 and 11, the most cytotoxic compounds of the whole series, could be due to the position of the condensed benzene ring, which favors d-d stacking interactions with purine and pyrimidine bases in the DNA active site. Biological studies suggested that 10-12 have no effect on human topoisomerases I and II and that they induce arrest at the G2/M phase.
    DOI:
    10.1021/jm050745l
  • 作为产物:
    描述:
    参考文献:
    名称:
    Schroeter, Justus Liebigs Annalen der Chemie, 1922, vol. 426, p. 132
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] METHOD FOR INDUSTRIALLY PREPARING NITROGEN SUBSTITUTED AMINO-5,6,7,8-TETRAHYDRONAPHTHOL<br/>[FR] PROCÉDÉ POUR LA PRÉPARATION INDUSTRIELLE D'AMINO-5,6,7,8-TÉTRAHYDRONAPHTOL SUBSTITUÉ PAR AZOTE
    申请人:SHAN DONG LUYE PHARM CO LTD
    公开号:WO2013000273A1
    公开(公告)日:2013-01-03
    A method for industrially preparing a nitrogen substituted 6-amino-5,6,7,8-tetrahydronaphthol is disclosed. The method comprises reacting a nitrogen substituted amino-5,6,7,8-tetrahydronaphthol compound of formula (II) with a 2-substituted ethyl sulfonate compound of formula (III) under an alkaline condition and in the presence of a sulfite.
    公开了一种工业制备氮取代6-氨基-5,6,7,8-四氢萘酚的方法。该方法包括在碱性条件下,在亚硫酸盐存在下,将式(II)的氮取代氨基-5,6,7,8-四氢萘酚化合物与式(III)的2-取代乙基磺酸酯化合物反应。
  • METHOD FOR INDUSTRIALLY PREPARING NITROGEN SUBSTITUTED AMINO-5,6,7,8-TETRAHYDRONAPHTHOL
    申请人:Meng Qingguo
    公开号:US20140121380A1
    公开(公告)日:2014-05-01
    A method for industrially preparing a nitrogen substituted 6-amino-5,6,7,8-tetrahydronaphthol is disclosed. The method comprises includes reacting a nitrogen substituted amino-5,6,7,8-tetrahydronaphthol compound of formula (II) with a 2-substituted ethyl sulfonate compound of formula (III) under an alkaline condition and in the presence of a sulfite.
    公开了一种工业制备氮取代6-氨基-5,6,7,8-四氢萘酚的方法。该方法包括在碱性条件下,在亚硫酸盐存在下,通过将式(II)的氮取代氨基-5,6,7,8-四氢萘酚化合物与式(III)的2-取代乙基磺酸酯化合物反应来实现。
  • Processes for the Preparation of Rotigotine and Intermediates Thereof
    申请人:Apotex Inc.
    公开号:US20170305877A1
    公开(公告)日:2017-10-26
    The present invention provides processes for the preparation of a compound of Formula 2 or a salt thereof, wherein R 1 is selected from the group consisting of H, C 1 -C 3 alkyl, and C(0)R 3 ; R 3 is selected from the group consisting of C 1 -C 6 alkyl, C 6 -C 10 aryl and C 7 -C 20 arylalkyl; the carbon atom marked with “*” is racemic, enantiomerically enriched in the (R)-configuration, or enantiomerically enriched in the (S)-configuration. Also provided are intermediate compounds of the processes.
    本发明提供了制备式2化合物或其盐的方法,其中R1选自H、C1-C3烷基和C(0)R3,R3选自C1-C6烷基、C6-C10芳基和C7-C20芳基烷基;标有“*”的碳原子是外消旋的,富集(R)-构型的对映体或富集(S)-构型的对映体。同时提供了所述方法的中间体化合物。
  • Schroeter, Justus Liebigs Annalen der Chemie, 1922, vol. 426, p. 132
    作者:Schroeter
    DOI:——
    日期:——
  • ENDODONTIC POST SYSTEM
    申请人:APOTEX INC.
    公开号:US20160297745A1
    公开(公告)日:2016-10-13
    The present invention provides processes for the preparation of a compound of Formula 2 or a salt thereof, wherein R 1 is selected from the group consisting of H, C 1 -C 3 alkyl, and C(0)R 3 ; R 3 is selected from the group consisting of C 1 -C 6 alkyl, C 6 -C 10 aryl and C 7 -C 20 arylalkyl; the carbon atom marked with “*” is racemic, enantiomerically enriched in the (R)-configuration, or enantiomerically enriched in the (S)-configuration. Also provided are intermediate compounds of the processes.
查看更多

同类化合物

(S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 顺式-4-(3,4-二氯苯基)-1,2,3,4-四氢N-叔丁氧羰基-1-萘胺 顺式-1-苯甲酰氧基-2-二甲基氨基-1,2,3,4-四氢萘 顺式-1,2,3,4-四氢-5-环氧丙氧基-2,3-萘二醇 顺式-(1S,4S)-N-甲基-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺扁桃酸盐 顺-5,6,7,8-四氢-6,7-二羟基-1-萘酚 顺-(+)-5-甲氧基-1-甲基-2-(二正丙基氨基)萘满马来酸 阿洛米酮 阿戈美拉汀杂质醇(A) 阿戈美拉汀杂质 钠2-羟基-7-甲氧基-1,2,3,4-四氢-2-萘磺酸酯 金钟醇 邻烯丙基苯基溴化镁 那高利特盐酸盐 那高利特 过氧化,1,1-二甲基乙基1,2,3,4-四氢-1-萘基 贝多拉君 螺<4.7>十二烷 蔡醇酮 萘磺酸,二癸基-1,2,3,4-四氢- 萘并[2,3-d]咪唑,2-乙基-5,6,7,8-四氢-(6CI) 萘亚胺 苯甲酸-(5,6,7,8-四氢-[2]萘基酯) 苯甲丁氮酮 苯甲丁氮酮 苯甲丁氮酮 苯并烯氟菌唑 舍曲林二甲基杂质盐酸盐 舍曲林EP杂质B 舍曲林 羟甲基四氢萘酚 美曲唑啉 罗替戈汀硫酸盐 罗替戈汀杂质18 罗替戈汀中间体 罗替戈汀中间体 罗替戈汀 罗替戈汀 纳多洛尔杂质 米贝地尔(二盐酸盐) 盐酸舍曲林 盐酸舍曲林 盐酸罗替戈汀 盐酸左布诺洛尔 盐酸四氢唑林 甲基缩合物 甲基6-[1-(3,5,5,8,8-五甲基-5,6,7,8-四氢-2-萘基)环丙基]烟酸酯 甲基-(2-吡咯烷-1-基甲基-1,2,3,4-四氢-萘-2-基)-胺 环丙烯并[a]茚,1-溴-1-氟-1,1a,6,6a-四氢-